Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Smart Material Has Potential for Diagnosing Diseases

By LabMedica International staff writers
Posted on 01 Dec 2011
A new "smart" material enables near-infrared light to penetrate over 10 cm into the human body. More...


Scientists at the University of California, San Diego Skaggs School Pharmacy and Pharmaceutical Sciences (CA, USA) reported development and successful initial testing of the first practical “smart” material to use near-infrared (NIR) light that can penetrate into the human body. It has great potential for use in diagnosing diseases and engineering new human tissues in the lab. The low-power NIR does not damage body tissues as it passes.

Plastics that disintegrate when hit with NIR, for instance, could be filled with anticancer medicine, injected into tumors, and release the medicine when hit with NIR. Current NIR-responsive smart materials require high-power NIR light, which could damage cells and tissues. The new smart polymer was developed that responds to low-power NIR light. Hit with low-power NIR, the new material breaks apart into small pieces that appear to be nontoxic to surrounding tissue.

The scientists who developed the smart material envision, for instance, putting the polymer in an implantable "hydrogel," a water-containing flexible material used for tissue engineering and drug delivery. A hydrogel with the new polymer could release medications or imaging agents when hit with NIR.

The report on the new polymer or plastic-like material, which has potential for use in diagnosing diseases and engineering new human tissues in the lab, appears in ACS' journal Macromolecules in October 2011.

Related Links:

University of California, San Diego Skaggs School Pharmacy and Pharmaceutical Sciences



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.